论文信息 - TOPICOP© scale for steroid phobia – difficulties and suggestions for application in clinical research - 字舞流文

TOPICOP© scale for steroid phobia – difficulties and suggestions for application in clinical research

Dear Editor,Perhaps almost as prevalent as topical corticosteroids (TCS) use, is the fear of using them. A systematic review of TCS phobia in atopic dermatitis (1) found a prevalence ranging from 2...

N. Chandran | E. Choi | Law Je Yin | T. Wei

[1] J. Barbieri,et al. Influence of "Not Relevant" Responses on the Dermatology Life Quality Index (DLQI) for Patients With Psoriasis in the United States. , 2019, JAMA dermatology.

[2] Å. Svensson,et al. Topical corticosteroid phobia in atopic dermatitis: International feasibility study of the TOPICOP score , 2017, Allergy.

[3] Alvin W. Li,et al. Topical Corticosteroid Phobia in Atopic Dermatitis: A Systematic Review , 2017, JAMA dermatology.

[4] V. Lee,et al. Correlations among steroid fear, acceptability, usage frequency, quality of life and disease severity in childhood eczema , 2015, The Journal of dermatological treatment.

[5] C. Leux,et al. TOPICOP©: A New Scale Evaluating Topical Corticosteroid Phobia among Atopic Dermatitis Outpatients and Their Parents , 2013, PloS one.

[6] H. Williams,et al. Topical corticosteroid phobia in patients with atopic eczema , 2000, The British journal of dermatology.